Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Guerini-Rocco

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Cancer Treatment Reviews|August 15, 2025
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research groupGiovanni Corso, Sherry Shen, Carmen Criscitiello, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2016
The Genomic Landscape of Male Breast CancersSalvatore Piscuoglio, Charlotte K Y Ng, Melissa P Murray, et al.
Virchows Archiv : an International Journal of Pathology|March 8, 2025
Implementing digital pathology: qualitative and financial insights from eight leading European laboratoriesXavier Matias-Guiu, Jordi Temprana-Salvador, Pablo Garcia Lopez, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE TrialElena Guerini-Rocco, Kathryn P Gray, Caterina Fumagalli, et al.
Seminars in Oncology|June 19, 2024
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatmentGiovanni Corso, Nicola Fusco, Elena Guerini-Rocco, et al.
Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Cancer Treatment Reviews|August 15, 2025
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research groupGiovanni Corso, Sherry Shen, Carmen Criscitiello, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2016
The Genomic Landscape of Male Breast CancersSalvatore Piscuoglio, Charlotte K Y Ng, Melissa P Murray, et al.
Virchows Archiv : an International Journal of Pathology|March 8, 2025
Implementing digital pathology: qualitative and financial insights from eight leading European laboratoriesXavier Matias-Guiu, Jordi Temprana-Salvador, Pablo Garcia Lopez, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE TrialElena Guerini-Rocco, Kathryn P Gray, Caterina Fumagalli, et al.
Seminars in Oncology|June 19, 2024
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatmentGiovanni Corso, Nicola Fusco, Elena Guerini-Rocco, et al.
Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Pageof 16